Manufacturing Daily Summary
Manufacturing Daily Summary: What Happened on October 8, 2026
LogiPharma interview puts a price on overqualified supply routes
A CPHI panel weighed CDMO consolidation against the need for flexible manufacturing partners.
-
P
Today in brief
At LogiPharma 2026, Mark Talens estimated that companies qualify logistics routes and backups 80% to 90% beyond what they need, creating substantial costs.1 At CPHI Milan, executives discussed how CDMO consolidation shapes the choice of manufacturing partners.2
Also worth knowing
-
P
Talens said modern tools can reduce the time to establish an alternative route from four months to days or weeks while maintaining product quality.1
-
Panelists weighed partner capacity, cost, flexibility, reach, and program-specific risks. Manufacturing outsourcing deal activity peaked in 2021, then continued at lower volume.2